| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/19/2004 | US20040162249 To inhibit the growth of tumor cells in mammals |
| 08/19/2004 | US20040162244 Novel peptides use as angiotensin converting enzyme inhibitor and preparation process thereof |
| 08/19/2004 | US20040162242 Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof |
| 08/19/2004 | US20040162241 Use of GLP-1 or analogs in treatment of myocardial infarction |
| 08/19/2004 | US20040162239 For therapy of diseases associated with aberrant vascularization |
| 08/19/2004 | US20040162238 using Zven1 and Zven2 polypeptides to increase chemokine production for treating intestinal motility disorders and improving gastrointestinal funciton |
| 08/19/2004 | US20040162237 Use of lp82 to treat body weight disorders |
| 08/19/2004 | US20040162236 Providing a sample; introducing the sample to an antibody that binds immunospecifically to the polypeptide (containing amino acids from 1 to 82 ); and determining the presence or amount of antibody bound to said polypeptide, thus determining the presence or amount of polypeptide in the sample |
| 08/19/2004 | US20040162234 Glycogen synthase kinase-3 inhibitors |
| 08/19/2004 | US20040162233 Administering agent in form of iodinated organic compound containing iodinated protein and/or its low molecular component which includes at least one of the following amino acids: phenylalanine and tryptophan |
| 08/19/2004 | US20040162232 To stimulate the endogenous production of Elastin or appear to enhance the elasticity of the skin |
| 08/19/2004 | US20040162231 Vasodilator pharmaceutical preparation and health food composition |
| 08/19/2004 | US20040161858 TNF binding ligands and antibodies |
| 08/19/2004 | US20040161849 Materials and methods relating to the transfer of nucleic acid into quiescent cells |
| 08/19/2004 | US20040161843 Administering a peptide fragments from proteins that function as T-cell epitopes of human cytomegalovirus(HCMV) in human are capable of directing human cytotoxic T lymphocytes (CTL) to recognize and lyse human cells to infection with HCMV |
| 08/19/2004 | US20040161840 Bax-Responsive genes for drug target identification in yeast and fungi |
| 08/19/2004 | US20040161837 Using affinity chromatography to isolate lysosomal proteins from mammalian milk; for enzyme replacement therapy and treating pompe's disease |
| 08/19/2004 | US20040161825 Sperm specific proteins |
| 08/19/2004 | US20040161824 expressed on the surface of sperm; can be used in contraceptive vaccine formulations; for drug screening; genetic engineering |
| 08/19/2004 | US20040161823 for treating, diagnosing, preventing, and drug screening; genetic engineering |
| 08/19/2004 | US20040161822 Protein having antithrombotic activity and method for producing the same |
| 08/19/2004 | US20040161814 for drug screening enzyme inhibitors using gel chromatography; bioassays; gene therapy; genetic engineering |
| 08/19/2004 | US20040161806 Cells having transferred proteins, and methods of use thereof |
| 08/19/2004 | US20040161795 Systems and methods for analysis of protein post-translational modification |
| 08/19/2004 | US20040161794 Identifying modulators of hypothalamic inhibitory factor for use in treatment, prevention and monitoring hypertension |
| 08/19/2004 | US20040161775 Comprises nucleotide fsequences which code apoptosis modulator protein for use in diagnosis and treatment of cell proliferation disorders |
| 08/19/2004 | US20040161758 Identifying/screening ruminant foods and products for presence of viral agents associated with spongiform encephalopathy; immunoassays |
| 08/19/2004 | US20040161745 Nucleotide sequences coding glucuronidase for identifying modulators for treatment of inflammation; wound healing agents and tissue repair |
| 08/19/2004 | US20040161739 HIV diagnostic methods |
| 08/19/2004 | US20040161483 Treating method for suppressing hair growth |
| 08/19/2004 | US20040161480 Antiinflammatory agents; repair of damage tissue; mixture of metabolites and plant extracts; synergistic mixture of chondroitin sulfate and glucosamine |
| 08/19/2004 | US20040161475 Anticancer, antitumor agents; ssynergistic mixtures with retinoic acid; olid tumors |
| 08/19/2004 | US20040161467 Particulate drug-containing products and method of manufacture |
| 08/19/2004 | US20040161458 Hard gelatin capsule containing mixture of surfactants |
| 08/19/2004 | US20040161443 Vehicle |
| 08/19/2004 | US20040161428 Such as transferrin-doxorubicin conjugate linked by gluteraldehyde; inexpensive, effective |
| 08/19/2004 | US20040161425 Chemokine receptor antagonists as therapeutic agents |
| 08/19/2004 | US20040161423 Extending biological half life; attaching to such as polyethylene glycol |
| 08/19/2004 | US20040161421 Intramyocardial injection of autologous bone marrow |
| 08/19/2004 | US20040161416 Delivering DNA sequence imparting sustained rheumatoid arthritis relief |
| 08/19/2004 | US20040161415 Inducted heat shock proteins in activated lymphocytes |
| 08/19/2004 | US20040161412 Cell-based VEGF delivery |
| 08/19/2004 | US20040161408 Uses of circadian gene mPer2 |
| 08/19/2004 | US20040161407 Medicinal compositions |
| 08/19/2004 | US20040161406 Use of interleukin-11 to treat gastrointestinal disorders |
| 08/19/2004 | US20040160876 Method for determining a tilt angle of an optical pickup head |
| 08/19/2004 | DE10305531A1 New tubulysin compound conjugates with polymers or biomolecules, having reduced toxicity compared with parent tubulysin, especially useful for treating tumor diseases |
| 08/19/2004 | CA2814767A1 Combination therapy for treating protein deficiency disorders |
| 08/19/2004 | CA2515644A1 Oligomeric compounds for the modulation of ras expression |
| 08/19/2004 | CA2515603A1 Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions |
| 08/19/2004 | CA2515339A1 Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long qt syndrome |
| 08/19/2004 | CA2515335A1 Growth factor complexes and modulation of cell migration and growth |
| 08/19/2004 | CA2515302A1 Sensitizing cells for apoptosis by selectively blocking cytokines |
| 08/19/2004 | CA2515297A1 Use of human chorionic gonadotropin in the treatment of symptoms caused by endometriosis |
| 08/19/2004 | CA2515294A1 Therapeutic agents for diabetes |
| 08/19/2004 | CA2515127A1 Peptidic sulfonamides |
| 08/19/2004 | CA2515123A1 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | CA2515122A1 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | CA2514986A1 Mucin-like polypeptides |
| 08/19/2004 | CA2514942A1 Methods and compositions for the treatment of parkinson's disease and other a-synucleinopathies |
| 08/19/2004 | CA2514841A1 Cell-killing molecules and methods of use thereof |
| 08/19/2004 | CA2514642A1 Combination therapy for treating protein deficiency disorders |
| 08/19/2004 | CA2514641A1 Methods for modulating an inflammatory response |
| 08/19/2004 | CA2514563A1 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | CA2514510A1 Polymer conjugates of mutated neublastin |
| 08/19/2004 | CA2514071A1 Therapeutic molecules |
| 08/19/2004 | CA2513731A1 Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases |
| 08/19/2004 | CA2513722A1 Active immunization to generate antibodies to soluble a-beta |
| 08/18/2004 | EP1447414A2 Agonist and antagonist peptides of carcinoembryonic antigen (CEA) |
| 08/18/2004 | EP1447408A1 Amino acid loaded trityl alcohol resins, method of production of amino acid loaded trityl alcohol resins and therapeutics produced therewith |
| 08/18/2004 | EP1447398A1 Retroviral protease inhibitors |
| 08/18/2004 | EP1447099A2 Antineoplastic polyethylene conjugates of cytostatic compounds and pharmaceuticals comprising same |
| 08/18/2004 | EP1447095A1 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant |
| 08/18/2004 | EP1447093A1 Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 08/18/2004 | EP1447090A2 Use of hyaluronidase for preventing and treating cardiovascular diseases |
| 08/18/2004 | EP1447089A2 Methods of treating hypertension and compositions for use therein |
| 08/18/2004 | EP1447088A1 Vasodilator pharmaceutical preparation and health food composition |
| 08/18/2004 | EP1446733A2 Glycosylphosphatidylinositol containing polypeptides |
| 08/18/2004 | EP1446503A2 Composition and methods for enhancing oligonucleotide-directed nucleic acid sequence alteration |
| 08/18/2004 | EP1446501A2 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 08/18/2004 | EP1446500A2 A method for regulating immune function in primates using the foxp3 protein |
| 08/18/2004 | EP1446489A2 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo |
| 08/18/2004 | EP1446478A2 Dimerized growth factor and materials and methods for producing it |
| 08/18/2004 | EP1446425A2 Treatment of micro-organism infection |
| 08/18/2004 | EP1446424A2 Composition comprising inhibitors of the notch signalling pathway for the modulation of the immune system |
| 08/18/2004 | EP1446423A2 Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders |
| 08/18/2004 | EP1446419A2 Therapeutic polypeptides, nucleic acids encoding the same, and methods of use |
| 08/18/2004 | EP1446418A2 Integrin targeting compounds |
| 08/18/2004 | EP1446417A2 Novel epidermal growth factor protein and gene, and methods of use therefor |
| 08/18/2004 | EP1446414A1 Differentially expressed genes associated with obesity and type 2 diabetes |
| 08/18/2004 | EP1446392A1 Oligopeptides and compositions containing them as cathepsin s inhibitors |
| 08/18/2004 | EP1446162A2 Combination motif immune stimulatory oligonucleotides with improved activity |
| 08/18/2004 | EP1446159A2 Immunotherapy for reversing immune suppression |
| 08/18/2004 | EP1446158A2 Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4 |
| 08/18/2004 | EP1446155A1 Pharmaceutical composition comprising factor vii polypeptides and aprotinin polypeptides |
| 08/18/2004 | EP1446154A1 Pharmaceutical composition comprising factor vii polypeptides and alpha2 -antiplasmin polypeptides |
| 08/18/2004 | EP1446153A1 Pharmaceutical composition comprising factor vii polypeptides and tissue plasminogen inhibitors |
| 08/18/2004 | EP1446152A1 Pharmaceutical composition comprising factor vii polypeptides and protein s inhibitors |
| 08/18/2004 | EP1446151A1 Pharmaceutical composition comprising factor vii polypeptides and thrombomodulin polypeptides |
| 08/18/2004 | EP1446150A1 Pharmaceutical composition comprising factor vii polypeptides and protein c inhibitors |